Beyond Guideline-Directed Medical Therapy: Nonpharmacologic Management for Patients With Heart Failure.

IF 10.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS JACC. Heart failure Pub Date : 2024-10-09 DOI:10.1016/j.jchf.2024.08.018
Onyedika J Ilonze, Daniel E Forman, Lisa LeMond, Jonathan Myers, Scott Hummel, Amanda R Vest, Ersilia M DeFilippis, Eiad Habib, Sarah J Goodlin
{"title":"Beyond Guideline-Directed Medical Therapy: Nonpharmacologic Management for Patients With Heart Failure.","authors":"Onyedika J Ilonze, Daniel E Forman, Lisa LeMond, Jonathan Myers, Scott Hummel, Amanda R Vest, Ersilia M DeFilippis, Eiad Habib, Sarah J Goodlin","doi":"10.1016/j.jchf.2024.08.018","DOIUrl":null,"url":null,"abstract":"<p><p>Heart failure (HF) is a leading cause of cardiovascular morbidity, mortality, and health care expenditure. Guideline-directed medical therapy and device-based therapy in HF are well established. However, the role of nonpharmacologic modalities to improve HF care remains underappreciated, is underused, and requires multimodal approaches to care. Diet, exercise and cardiac rehabilitation, sleep-disordered breathing, mood disorders, and substance use disorders are potential targets to reduce morbidity and improve function of patients with HF. Addressing these factors may improve symptoms and quality of life, reduce hospitalizations, and improve mortality in heart failure. This state-of-the-art review discusses dietary interventions, exercise programs, and the management of sleep-disordered breathing, mood disorders, and substance use in individuals with heart failure. The authors review the latest data and provide optimal lifestyle recommendations and recommended prescriptions for nonpharmacologic therapies.</p>","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":" ","pages":""},"PeriodicalIF":10.3000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Heart failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jchf.2024.08.018","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Heart failure (HF) is a leading cause of cardiovascular morbidity, mortality, and health care expenditure. Guideline-directed medical therapy and device-based therapy in HF are well established. However, the role of nonpharmacologic modalities to improve HF care remains underappreciated, is underused, and requires multimodal approaches to care. Diet, exercise and cardiac rehabilitation, sleep-disordered breathing, mood disorders, and substance use disorders are potential targets to reduce morbidity and improve function of patients with HF. Addressing these factors may improve symptoms and quality of life, reduce hospitalizations, and improve mortality in heart failure. This state-of-the-art review discusses dietary interventions, exercise programs, and the management of sleep-disordered breathing, mood disorders, and substance use in individuals with heart failure. The authors review the latest data and provide optimal lifestyle recommendations and recommended prescriptions for nonpharmacologic therapies.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
超越指南指导下的药物治疗:心力衰竭患者的非药物治疗。
心力衰竭(HF)是心血管疾病发病率、死亡率和医疗支出的主要原因。以指南为指导的药物治疗和以器械为基础的治疗在心力衰竭领域已得到广泛认可。然而,非药物疗法在改善心房颤动护理方面的作用仍未得到充分重视和利用,并且需要多模式的护理方法。饮食、运动和心脏康复、睡眠呼吸障碍、情绪障碍和药物使用障碍是降低心房颤动患者发病率和改善其功能的潜在目标。解决这些因素可改善心衰患者的症状和生活质量,减少住院次数,并提高死亡率。这篇最新综述讨论了饮食干预、运动计划以及心力衰竭患者的睡眠呼吸障碍、情绪障碍和药物使用管理。作者回顾了最新数据,并提供了最佳生活方式建议和非药物疗法的推荐处方。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
JACC. Heart failure
JACC. Heart failure CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
21.20
自引率
2.30%
发文量
164
期刊介绍: JACC: Heart Failure publishes crucial findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients. The goal is to enhance understanding through timely scientific communication on disease, clinical trials, outcomes, and therapeutic advances. The Journal fosters interdisciplinary connections with neuroscience, pulmonary medicine, nephrology, electrophysiology, and surgery related to heart failure. It also covers articles on pharmacogenetics, biomarkers, and metabolomics.
期刊最新文献
Early Heart Failure Outcomes and Medical Therapy Use in a Virtually Managed Hospital-at-Home Setting. The Association of Echocardiographically Measured Donor Left Ventricular Mass and 1-Year Outcomes After Heart Transplantation. Donor Selection for Heart Transplantation in 2024. Symptoms Burden as a Clinical Outcomes Assessment in Heart Failure Patients With Atrial Fibrillation. Association of Histologic Findings With Long-Term Outcomes in Symptomatic Obstructive Hypertrophic Cardiomyopathy Patients Undergoing Surgical Myectomy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1